共 50 条
- [33] Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma MEDICINA-LITHUANIA, 2025, 61 (01):
- [34] Metabolic dysfunction-associated fatty liver disease is a ubiquitous latent cofactor in viral- and alcoholic-related hepatocellular carcinoma: Editorial on "Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis" CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (04)
- [35] Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01):
- [36] Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease Diabetology & Metabolic Syndrome, 14
- [39] Impact of metabolic dysfunction-associated fatty liver disease on liver transplant recipients with hepatitis B virus-related hepatocellular carcinoma European Journal of Clinical Nutrition, 2024, 78 : 107 - 113